HealthSonix Announces ZingiberRx Joint and Muscle Cream Marketing Programme Soaring

February 27, 2008 (BUSINESS WIRE) -- HealthSonix, Inc. OTC:HSXI)(FWB:H7S) nowadays announced that the multi-faceted marketing program for ZingiberRx Joint and Muscle Cream launched earlier this month is hitting stride and exceeding corporation expectations. The program consisted of launching the website, sampling, regulate to consumer sales, test markets in retail stores, and advertising on Google search engines.

Yesterday alone, we had over 5,300 visits to our website and received over 5,000 requests for samples," said Dieter D. Doederlein, Vise Head of the state of Corporate Development for HealthSonix.

This is significant considering early evidence suggests that we have a high-reaching conversion scale from principles to purchase, and we last to buy positive feedback from users of all ages."

In appendix to the frank to consumer marketing efforts, we hog been corroboration marketing the product in local narcotic stores and retain forthwith progressed to Vendor status with one of the largest public drug store chains in Canada. ZingiberRx is de facto the number one selling topical martyrdom reliever in distinct of the early test locations and we include the all-inclusive base and training of the pharmacists when it comes to explaining the product and its benefits," added Doederlein.

The response to this different despondency relieving cream, the front of its kind with ginger, is even-handed short of amazing. It is really rewarding to witness the immediate acceptance of ZingiberRx for the relief of agony and inflammation." ZingiberRx seam and muscle cream is quick acting, non-staining, fast absorbing, and deep-seated penetrating. Unlike most over-the-counter topical ointments, ZingiberRx is not a counter-irritant and does not build a fiery or a below zero sensation when applied.

Medical analysis studies into the medicinal properties of changeable plants in the ginger (Zingiberaceae) family chalk up remoted the Zingiber cassumunar species for its anti-inflammatory, anti-allergic and hurt relieving properties. HealthSonix, Inc. OTC:HSXI)(FWB:H7S) is a publicly traded trial oriented medical technology society that develops and markets medical devices and healthcare products for institutional and consumer use.

The company's patent pending medical devices deliver sound coercion waves to the human protest for relief of bitterness and other musculoskeletal conditions. The cynosure is on arthritis, athletic injuries and conditions where acute or chronic affliction is the main symptom. And information regarding HealthSonix, Inc.

Environment Broad Lattice at: www.HealthSonix.com or by calling the association at 1-877-622-2121.

Note: A number of statements contained in this news proceeds are forward-looking statements, which are specious pursuant to the Protected Harbor food of the Private Securities Litigation Ameliorate Reality of 1995.

These forward-looking statements contain a figure of risks and uncertainties, including the well timed adding to and bazaar acceptance of products and technologies, competitive conditions, extraordinary integration of acquisitions, the ability to secure further sources of financing, the influence to section operating expenses and other factors not establish forth herein. The actual results that the Convention may acquire may differ materially from any forward-looking statements due to such risks and uncertainties.

SOURCE: HealthSonix, Inc. Dieter D. Jobs at FOX Metier Network. Terms of use. Privacy Statement. This material may not be published, broadcast, rewritten, or redistributed. 2008 FOX Facts Network, LLC. All rights reserved. SmartMoney is a joint dare between Dow Jones & Company, Inc. Hearst SM Partnership. All Rights Reserved. All quotes delayed by 20 minutes.

Delayed quotes if by Interactive Material Managed Solutions. Historical prices and essential counsel provided by Hemscott, Inc. Mutual fund info provided by Lipper. Mutual Fund NAVs are as of preceding day's close. Emoluments estimates provided by Zacks Investment Research. Insider trading information provided by Thomson Financial.